Michel Obéid
University Hospital of Lausanne(CH)University of Lausanne(CH)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immune Cell Function and Interaction, Phagocytosis and Immune Regulation, Immunotherapy and Immune Responses
Most-Cited Works
- → Calreticulin exposure dictates the immunogenicity of cancer cell death(2006)3,040 cited
- → Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy(2007)2,933 cited
- → Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance(2019)2,170 cited
- → Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death(2005)1,455 cited
- → Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up(2022)1,025 cited
- → Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis(2007)458 cited
- → Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy(2020)226 cited
- → Ecto‐calreticulin in immunogenic chemotherapy(2007)192 cited
- → New therapeutic perspectives to manage refractory immune checkpoint-related toxicities(2019)184 cited
- → Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy(2021)181 cited